<SEC-DOCUMENT>0001969223-24-000480.txt : 20240614
<SEC-HEADER>0001969223-24-000480.hdr.sgml : 20240614
<ACCEPTANCE-DATETIME>20240614163948
ACCESSION NUMBER:		0001969223-24-000480
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240614
DATE AS OF CHANGE:		20240614

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Black Diamond Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001701541
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-39200
		FILM NUMBER:		241045472

	BUSINESS ADDRESS:	
		STREET 1:		ONE MAIN STREET, 14TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-417-5868

	MAIL ADDRESS:	
		STREET 1:		ONE MAIN STREET, 14TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aset Therapeutics, Inc.
		DATE OF NAME CHANGE:	20170321

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Epstein David M.
		CENTRAL INDEX KEY:			0001488668
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		OSI PHARMACEUTICALS, INC.
		STREET 2:		41 PINELAWN ROAD
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001488668</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001701541</issuerCik>
      <issuerName>Black Diamond Therapeutics, Inc.</issuerName>
      <secFileNumber>001-39200</secFileNumber>
      <issuerAddress>
        <com:street1>One Main Street</com:street1>
        <com:street2>14th Floor</com:street2>
        <com:city>Cambridge</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>02142</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>6172520848</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>David Epstein</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Former Board Member</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Class A Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>UBS Financial Services Inc</name>
        <address>
          <com:street1>1000 Harbor Blvd</com:street1>
          <com:street2>3rd Floor</com:street2>
          <com:city>Weehawken</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>07086</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>24621</noOfUnitsSold>
      <aggregateMarketValue>148464.63</aggregateMarketValue>
      <noOfUnitsOutstanding>56252794</noOfUnitsOutstanding>
      <approxSaleDate>06/14/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Class A Common Stock</securitiesClassTitle>
      <acquiredDate>09/19/2016</acquiredDate>
      <natureOfAcquisitionTransaction>Founders Shares</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Black Diamond Therapeutics Inc</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>421665</amountOfSecuritiesAcquired>
      <paymentDate>09/19/2016</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>David Epstein</name>
        <address>
          <com:street1>56 Pine St</com:street1>
          <com:city>Belmont</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02478</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Black Diamond Therapeutics, Inc.</securitiesClassTitle>
      <saleDate>06/12/2024</saleDate>
      <amountOfSecuritiesSold>62528</amountOfSecuritiesSold>
      <grossProceeds>383921</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>David Epstein</name>
        <address>
          <com:street1>56 Pine St</com:street1>
          <com:city>Belmont</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02478</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Black Diamond Therapeutics, Inc.</securitiesClassTitle>
      <saleDate>06/13/2024</saleDate>
      <amountOfSecuritiesSold>70853</amountOfSecuritiesSold>
      <grossProceeds>435745</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>06/14/2024</noticeDate>
      <signature>/s/ UBS Financial Services Inc, as attorney-in-fact for David Epstein</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
